BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10723586)

  • 21. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
    Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E
    Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent presence of both patient and donor t(14;18) in a follicular lymphoma patient after undergoing allogeneic BMT: implications for minimal residual disease detection post-transplant.
    Rosenblum MD; Drobyski WR; Keever-Taylor C; Chang CC
    Bone Marrow Transplant; 2003 May; 31(10):947-9. PubMed ID: 12748676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity and reproducibility of conventional qualitative and quantitative PCR assays for detection of the t(14;18)(q32;q21) chromosomal translocation in biopsy material from patients with follicular lymphoma.
    Kokovic I; Novakovic BJ; Grazio SF; Novakovic S
    Int J Mol Med; 2009 Jan; 23(1):9-15. PubMed ID: 19082502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?
    Schmitt C; Grundt A; Buchholtz C; Scheuer L; Benner A; Hensel M; Ho AD; Leo E
    Leuk Res; 2006 Dec; 30(12):1563-8. PubMed ID: 16530831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Minimal residual disease in follicular and mantle cell lymphoma. Detection using quantitative molecular monitoring of circulating lymphoma cells].
    Schüler F; Hirt C; Dölken L; Krüger W; Dölken G
    Dtsch Med Wochenschr; 2005 Sep; 130(38):2130-4. PubMed ID: 16172952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach.
    Deggerdal AH; Pettersen F; Kvalheim G; Hornes E; Smeland E; Fodstad O; Hovig E
    Lab Invest; 1995 Apr; 72(4):411-8. PubMed ID: 7723279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [PCR study of bcl-2 rearrangement in autologous transplantation of peripheral stem cells in follicular non-Hodgkin's lymphoma].
    Ataulfo González F; Armada B; Villegas A; Llorente L; Pérez J; Díaz Mediavilla J; del Potro E; Martínez R; Alvarez A; Espinós D
    Med Clin (Barc); 1997 May; 108(19):730-3. PubMed ID: 9324596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
    Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
    Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
    Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
    Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follicular lymphoma: quantitation of minimal residual disease by PCR of the t(14;18) translocation.
    Darby A; Gribben JG
    Methods Mol Med; 2005; 115():315-31. PubMed ID: 15998976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
    Rohatiner AZ; Nadler L; Davies AJ; Apostolidis J; Neuberg D; Matthews J; Gribben JG; Mauch PM; Lister TA; Freedman AS
    J Clin Oncol; 2007 Jun; 25(18):2554-9. PubMed ID: 17515573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma.
    Friedberg JW; Kim H; Li S; Neuberg D; Boyd K; Daley H; Fisher DC; Gribben JG; Spitzer T; Freedman AS
    Bone Marrow Transplant; 2003 Oct; 32(7):681-6. PubMed ID: 13130315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of detecting strong bcl-2 protein expression with flow cytometry in follicular lymphoma].
    Kobayashi S; Motomura S; Kishi Y; Hashimoto C; Maruta A; Kodama F
    Rinsho Ketsueki; 2004 Jul; 45(7):530-8. PubMed ID: 15359912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
    Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
    Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma.
    Bendandi M; Gocke CD; Kobrin CB; Benko FA; Sternas LA; Pennington R; Watson TM; Reynolds CW; Gause BL; Duffey PL; Jaffe ES; Creekmore SP; Longo DL; Kwak LW
    Nat Med; 1999 Oct; 5(10):1171-7. PubMed ID: 10502821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of t(14;18) in follicular lymphoma by dual-color fluorescence in situ hybridization on paraffin-embedded tissue sections.
    Matsumoto Y; Nomura K; Matsumoto S; Ueda K; Nakao M; Nishida K; Sakabe H; Yokota S; Horiike S; Nakamine H; Nakamura S; Taniwaki M
    Cancer Genet Cytogenet; 2004 Apr; 150(1):22-6. PubMed ID: 15041219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stage I/II follicular lymphoma: spread of bcl-2/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy.
    Pulsoni A; Starza ID; Frattarelli N; Ghia E; Carlotti E; Cavalieri E; Matturro A; Tempera S; Rambaldi A; Foà R
    Br J Haematol; 2007 May; 137(3):216-20. PubMed ID: 17408460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-dependent prevalence and frequency of circulating t(14;18)-positive cells in the peripheral blood of healthy individuals.
    Dölken G; Dölken L; Hirt C; Fusch C; Rabkin CS; Schüler F
    J Natl Cancer Inst Monogr; 2008; (39):44-7. PubMed ID: 18648002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.